Tag: pharmaceuticals
-
Trial Testing Lymphoma Drug to Treat Covid-19
A clinical trial is underway testing an experimental drug for lymphoma and neurological disorders also as a treatment for early Covid-19 infections.
-
Covid-19 Vaccines, Therapies – 27 July 2020
This week’s chart shows since last Monday more new activity for therapies than vaccines, with 15 new Covid-19 therapies joining the array of treatments in development.
-
Synthetic Protein Designed to Boost Covid-19 Vaccines
Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines.
-
Advanced Solid Tumor Precision Meds. Trial Begins
A clinical trial is underway testing a treatment for advanced-stage cancers that blocks amino acids allowing nutrients to feed the growth of solid tumors.
-
Start-Up Developing Inside-Cell Delivery, Gains $28.5M
A new company spun-off from Harvard University is developing techniques for delivering advanced genetic and protein therapies directly inside cells.
-
Gene Therapy Production Company Opens, Raises $40M
A new enterprise developing and manufacturing gene therapies, both its own and for others, is underway, raising $40 million in venture funds.
-
Oxford Covid-19 Vaccine Trial Invokes Immune Responses
Results from a clinical trial testing a Covid-19 vaccine show the vaccine invokes two types of immune responses without serious adverse effects.
-
Covid-19 Vaccines, Therapies – 20 July 2020
This week, the data show a sharp jump in new Covid-19 therapy projects, with 17 new treatments reported raising the total to 322.
-
Start-Up Developing Coronavirus Antibodies, Raises $50M
A new company is underway creating engineered antibodies to neutralize a range of coronaviruses, not just those causing Covid-19 infections.
-
Cancer Protein Therapy Biotech Raises $400M in IPO
A three year-old company developing protein-targeted cancer therapies with computational techniques is raising $400 million in its initial public offering of common stock.